ORIN1001

· Orinove, Inc.

Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for ORIN1001, covering 2024-12-31 to 2025-05-30. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of Oral ORIN1001 in Subjects With Idiopathic Pulmonary Fibrosis (IPF) [Phase 1]